Kenneth A. Stauderman
CIK 1969388 · View on SEC EDGAR ↗
First SEC filing: May 10, 2023 · Latest: May 10, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | CALC | A | 68,988 | — | — | 68,988 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 1,877 | — | — | 1,877 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 18,991 | — | — | 18,991 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 2,090 | — | — | 2,090 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 1,954 | — | — | 1,954 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 661 | — | — | 661 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 5,472 | — | — | 5,472 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 7,264 | — | — | 7,264 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 13,147 | — | — | 13,147 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 7,264 | — | — | 7,264 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 21,647 | — | — | 21,647 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 8,640 | — | — | 8,640 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 22,777 | — | — | 22,777 Direct | — | Acquired | (price as of 2026-08-19) |
| March 20, 2023 | CALC | A | 11,944 | — | — | 11,944 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 8, 2023 | CALC | Employee Stock Option (Right to Buy) | Common Stock (68,988) | $3.25 | May 7, 2033 | 68,988 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (1,877) | $17.34 | March 19, 2023 | 1,877 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (18,991) | $17.34 | March 19, 2033 | 18,991 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (2,090) | $17.34 | March 19, 2033 | 2,090 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (1,954) | $10.42 | Aug. 30, 2032 | 1,954 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (661) | $10.42 | Aug. 30, 2032 | 661 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (5,472) | $19.45 | July 12, 2032 | 5,472 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (7,264) | $7.99 | June 30, 2031 | 7,264 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (13,147) | $7.99 | April 27, 2031 | 13,147 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (7,264) | $7.99 | April 27, 2031 | 7,264 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (21,647) | $6.60 | June 29, 2030 | 21,647 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (8,640) | $2.44 | April 24, 2029 | 8,640 | Acquired |
| March 20, 2023 | CALC | Employee Stock Option (right to buy) | Common Stock (22,777) | $2.44 | Aug. 1, 2028 | 22,777 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CALC
Ph.D.(4) Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $266,667 | $210,000 | — | — | $62,940 | — | $1,854 | $696,859 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.